Karyopharm Therapeutics
KPTI
KPTI
154 hedge funds and large institutions have $334M invested in Karyopharm Therapeutics in 2022 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 63 increasing their positions, 39 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.22% more ownership
Funds ownership: 5.57% → 5.79% (+0.22%)
8% less capital invested
Capital invested by funds: $364M → $334M (-$29.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
154
Holding in Top 10
–
Calls
$1.83M
Puts
$1.12M
Top Buyers
| 1 | +$32.8M | |
| 2 | +$14.6M | |
| 3 | +$13.1M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$6.97M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.76M |
Top Sellers
| 1 | -$4.96M | |
| 2 | -$4.09M | |
| 3 | -$3.44M | |
| 4 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$2.62M |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.46M |